[April 29, 2015]

Research and Markets: Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Research and Markets (http://www.researchandmarkets.com/research/3fxx74/pharmacovigilance) has announced the addition of the "Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering.

The global pharmacovigilance market is segmented on the basis of clinical trial phases, type of methods, service providers, and geography.

Based on clinical trial phases, the pharmacovigilance market is segmented into preclinical studies, phase I trial, phase II trial, phase III trial, and phase IV trial (post marketing surveillance).

Based on the methods, this study segments the market into spontaneous reporting, targeted reporting, cohort event monitoring, Intensified ADR, and Reporting EHR mining.

Based on service providers, the global pharmacovigilace market is categorized into in-house and contract outsourcing. The market size estimations for the period from 2012 to 2020 have been provided for each segment in terms of USD million.

Compounded annual growth rates (CAGR %) for each segment has been provided for the period between 2014 and 2020, considering 2013 as the base year.

The global pharmacovigilance market is segmented as follows:

Pharmacovigilance Market, by Phases of Drug Development

- Preclinical Studies

- Phase I

- Phase II

- Phase III

- Phase IV or Post Marketing Surveillance

Pharmacovigilance Market, by Type of Methods

- Spontaneous Reporting

- Intensified ADR Reporting

- Targeted Spontaneous Reporting

- Cohort Event Monitoring

- EHR Mining

Pharmacovigilance Market, by Type of Service

- In-House

- Contract Outsourcing

Companies Mentioned

- Accenture (News - Alert) plc

- Bristol-Myers Squibb

- Clinquest Group B.V.

- Cognizant Technology Solutions

- Covance, Inc.

- F. Hoffmann-La Roche Ltd.

- GlaxoSmithKline plc (GSK)

- ICON plc

- iGATE Corporation

- iMEDGlobal Corporation

- inVentiv Health, Inc.

- Novartis International AG

- PAREXEL International Corporation

- Pfizer, Inc.

- Pharmaceutical Product Development, LLC. (PPD)

- PRA Health Sciences, Inc.

- Quintiles Transnational Holdings, Inc.

- Sanofi

- Synowledge LLC

- Wipro (News - Alert) Limited

For more information visit http://www.researchandmarkets.com/research/3fxx74/pharmacovigilance

[ Back To TMCnet.com's Homepage ]